Screener / SEC EDGAR /CIK 0001113232 /10-K filed Feb 26, 2026, compared with Feb 28, 2025 /Numbers from the XBRL of the 10-Ks
Industrials peers:
Nasdaq Industrials · Industrial Machinery

Axcelis Technologies Inc ACLS

Axcelis Technologies, Inc. (“Axcelis,” the “Company,” “we,” “us,” or “our”) designs, manufactures and services ion implantation and other processing equipment used in the fabrication of semiconductor chips. 10-K, Item 1

Employees
1,465
Headquarters
Beverly, MA
CEO
Russell Low
Next results
around Feb 16, 2027
Compare with peers Embed

Where each dollar of revenue went, FY2025

Revenue of $839.0M through the costs to a net profit of $120.2M · income statement of the 10-K

14% operating margin
Revenue to Gross profit: $376.8MRevenue to Cost of revenue: $462.2MGross profit to Operating profit: $119.3MGross profit to Operating expenses: $257.5MOperating profit to Net profit: $101.3MOperating profit to Tax: $18.0MOther income to Net profit: $18.9MOperating expenses to R&D: $109.0MOperating expenses to Sales, admin & other: $148.6M Revenue: $839.0M REVENUE $839.0M −18% Y/Y Gross profit: $376.8M · 45% margin GROSS PROFIT $376.8M 45% margin · −17% Y/Y Cost of revenue: $462.2M · 55% of revenue COST OF REVENUE $462.2M 55% of revenue Operating profit: $119.3M · 14% margin OPERATING PROFIT $119.3M 14% margin · −43% Y/Y Other income: $18.9M · 2% of revenue OTHER INCOME $18.9M 2% of revenue Operating expenses: $257.5M · 31% of revenue OPERATING EXPENSES $257.5M 31% of revenue Net profit: $120.2M · 14% margin NET PROFIT $120.2M 14% margin · −40% Y/Y Tax: $18.0M · 2% of revenue TAX $18.0M 2% of revenue R&D: $109.0M · 13% of revenue R&D $109.0M 13% of revenue Sales, admin & other: $148.6M · 18% of revenue SALES, ADMIN & OTHER $148.6M 18% of revenue
Gross profit $376.8M 45% margin · −17% Y/Y
Operating profit $119.3M 14% margin · −43% Y/Y
Net profit $120.2M 14% margin · −40% Y/Y
The full income statement, year by year

ACLS among Industrials peers

Six ratios from the latest 10-K. Each corner is the share of 251 peers the company is above, not a score.

Compare
Revenue growth: -17.6%, above 1% of 250 peers (their median 5.7%) REVENUE GROWTH -17.6% · above 1% Gross margin: 42.8%, above 80% of 177 peers (their median 34.1%) GROSS MARGIN 42.8% · above 80% Operating margin: 10.3%, above 43% of 229 peers (their median 11.8%) OPERATING MARGIN 10.3% · above 43% Net margin: 11.7%, above 66% of 251 peers (their median 8.1%) NET MARGIN 11.7% · above 66% FCF margin: 6.7%, above 33% of 234 peers (their median 9.6%) FCF MARGIN 6.7% · above 33% Return on capital: 9.3%, above 43% of 193 peers (their median 10.4%) RETURN ON CAPITAL 9.3% · above 43%
ACLS Peer median Below the median

What changed

53 new risk paragraphs and 2 accounting facts worth reading about. 10-K filed Feb 26, 2026 against Feb 28, 2025.

Each row opens the detail with the quote and the filing. A row is a change worth reading, not a verdict.

Accounting checks

11 checks on the latest 10-K. Checks, not verdicts.

How it works

2facts worth reading about the other 9 checks found nothing to note

  • Cash from operations lower than net income
    Cash from operations $118.3M vs net income $120.2M (FY ending Dec 31, 2025)
  • Inventory growing faster than revenue
    Inventory +16.6% ($282.2M to $329.0M) vs revenue -17.6% ($1.0B to $839.0M), +34.1 pts apart
  • Receivables -17.1% ($203.1M to $168.5M) vs revenue -17.6% ($1.0B to $839.0M), +0.5 pts apart
8 more checks with nothing to note
  • Same auditor in both 10-Ks: Ernst & Young LLP
  • No statement of substantial doubt about going concern
  • No 8-K item 4.02 in the last 2 years
  • No NT 10-K or NT 10-Q in the last 2 years
  • The same matters as last year: Systems Revenue recognition; Estimate of Excess Inventory
  • No sentence in the 10-K concludes that controls were not effective because of a material weakness
  • No 8-K item 2.06 in the last 2 years
  • No 8-K item 1.03 in the last 2 years

In their words

53 paragraphs in Risk Factors that were not in the 10-K filed Feb 28, 2025. Quoted as filed.

All 53 new paragraphs
  1. Item 1A · new paragraph · not in the 10-K filed Feb 28, 2025 10-K, ITEM 1A
    Robert J. Mahoney, 64, became Axcelis’ Executive Vice President, Global Operations in 2025, having formerly served as Senior Vice President, Global Operations since 2014. He has responsibility for all aspects of production, including the manufacturing, logistics, global sourcing, facilities and EHS organizations. Mr. Mahoney joined…
  2. Item 1A · new paragraph · not in the 10-K filed Feb 28, 2025 10-K, ITEM 1A
    The impact of tariffs on our business is difficult to predict, and may change substantially and without notice. The U.S. government has proposed or enacted tariffs and substantial changes to trade policies, which could adversely affect our business. In August 2025, the U.S. Court of Appeals for the Federal Circuit ruled that the tariffs…
  3. Item 1A · new paragraph · not in the 10-K filed Feb 28, 2025 10-K, ITEM 1A
    We are also subject to laws and regulations in various jurisdictions that determine how much profit has been earned and when it is subject to taxation in that jurisdiction. In the United States, for example, the One Big Beautiful Bill Act (“OB3”) was enacted in the third quarter of 2025. For the year ended December 31, 2025, the OB3 did…
  4. Item 1A · new paragraph · not in the 10-K filed Feb 28, 2025 10-K, ITEM 1A
    The exchange ratio is fixed and will not be adjusted in the event of any change in either Axcelis’ or Veeco’s stock price. Upon completion of the merger, each share of Veeco common stock issued and outstanding immediately prior to the Merger will be converted into and become exchangeable for 0.3575 shares of Axcelis common stock. This…

New risk paragraphs, against peers

Latest 10-K of each, Industrials companies closest in revenue

Paragraphs in Risk Factors with nothing like them in the company's 10-K the year before. A count of text, not of risk.

Financial performance

Last 4 fiscal years · 10-K XBRL

All years
MetricFY2022FY2023FY2024FY2025
Revenue$920.0M$1.1B$1.0B$839.0M
Net income$183.1M$246.3M$201.0M$120.2M
Operating cash flow$215.6M$156.9M$140.8M$118.3M
Free cash flow$204.9M$136.2M$128.6M$107.0M

Revenue, FY2016 to FY2025

Ten fiscal years, each from its own 10-K · XBRL · USD

$839.0M ▼ 17.6% in FY2025

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Every number, year by year

Recent filings

4 filings in the last 30 days · SEC EDGAR

All filings

About the company

Axcelis Technologies Inc, Beverly, MA · from the 10-K filed Feb 26, 2026

Axcelis Technologies, Inc. (“Axcelis,” the “Company,” “we,” “us,” or “our”) designs, manufactures and services ion implantation and other processing equipment used in the fabrication of semiconductor chips. We believe that our Purion family of products offers the most innovative implanters available on the market today. We sell to leading semiconductor chip manufacturers worldwide. The ion implantation business represented 98.2% of our revenue in 2025, with the remaining 1.8% of revenue derived from aftermarket sales associated with other legacy processing systems.

Headquarters
Beverly, MA
Country
United States
Reports in
USD
Listed on
Nasdaq
Fiscal year ends
December 31
Last results
Nov 5, 2026
Incorporated in
DE

Employees, at the top of the page: "As of December 31, 2025, we had 1,465 employees and 50 agency temporary staff worldwide" (10-K). Address and exchange: SEC's company file.

Email alerts

Sources

The 10-K filed Feb 26, 2026 (open at SEC), compared with the 10-K filed Feb 28, 2025. Numbers from the XBRL of the 10-Ks; filings from SEC EDGAR.

Work with it: Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/ACLS/export.csv") into a cell.

Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.